Lumasiran is an RNA interference (RNAi) therapy used to treat primary hyperoxaluria type 1 (PH1). It is a subcutaneous injection that works by reducing the amount of the enzyme alanine-glyoxylate aminotransferase (AGT) in the liver. AGT is responsible for the production of oxalate, a substance that can build up and cause damage to the kidneys, urinary tract, and other organs. By reducing the amount of AGT, Lumasiran helps lower oxalate levels in the body, thereby reducing the risk of complications from PH1. Lumasiran is the first and only approved treatment for PH1 in the United States, and is an important advancement in the treatment of this rare genetic disorder.
Lumasiran is a medication used to treat a specific inherited liver disorder called primary hyperoxaluria type 1 (PH1) in adults and children aged 6 years and older. Here's a breakdown of its key aspects:
- Function: Lumasiran belongs to a class of drugs called small interfering RNAs (siRNAs). It works by targeting a specific messenger RNA (mRNA) molecule involved in the production of oxalate in the liver [1, 2]. By reducing the production of this molecule, Lumasiran helps lower oxalate levels in the body.
Applications: Lumasiran is particularly useful for managing PH1, a condition where the body produces excess oxalate, a waste product. This excess oxalate can lead to kidney stones, kidney damage, and other complications [1].
Dosage and Forms: Lumasiran is administered as an injection under the skin (subcutaneous injection) by a healthcare professional, typically once every three weeks [1]. The exact dosage regimen depends on the patient's weight and overall health.
Important Considerations:
- Specialized Therapy: Lumasiran is a complex medication requiring special handling and administration by a healthcare provider trained in its use [2].
- Not a cure: Lumasiran helps manage PH1 by lowering oxalate levels, but it is not a cure for the condition. Long-term treatment is usually needed [2].
- Side effects: Injection site reactions, fatigue, headache, and nausea are some potential side effects [1]. It's crucial to report any side effects to your doctor.
- Monitoring: Regular monitoring by a doctor is essential while taking Lumasiran. This may include blood tests, urine tests, and monitoring for side effects [2].
- Interactions: Lumasiran can interact with other medications. It's important to disclose all medications you take to your doctor before starting treatment.